OTLK short interest
Outlook Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 31,896,591 |
|---|---|
| Change vs prior report | -323,911 (-1.0%) |
| Change over six months | +902.9% |
| Days to cover | 7.11 (sector: 3.78) |
| Average daily volume | 4,488,940 |
| Rank in Healthcare | #241 of 922 by days to cover |
OTLK short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 31,896,591 | -1.0% | 7.11 | 4,488,940 |
| 2026-09-15 | 32,220,502 | -2.1% | 7.67 | 4,202,688 |
| 2026-08-31 | 32,910,138 | +65.4% | 1.64 | 20,062,834 |
| 2026-08-14 | 19,899,576 | -0.6% | 1.00 | 24,240,333 |
| 2026-07-31 | 20,013,892 | +78.0% | 1.09 | 18,337,663 |
| 2026-07-15 | 11,240,969 | -19.8% | 1.24 | 9,099,076 |
| 2026-06-30 | 14,014,673 | +3.2% | 1.00 | 15,859,040 |
| 2026-06-15 | 13,576,714 | -15.8% | 1.00 | 21,412,461 |
| 2026-05-29 | 16,133,268 | +77.5% | 1.00 | 65,462,641 |
| 2026-05-15 | 9,088,387 | +41.3% | 2.19 | 4,150,596 |
| 2026-04-30 | 6,433,813 | +37.3% | 1.20 | 5,340,196 |
| 2026-04-15 | 4,686,225 | +47.3% | 1.02 | 4,590,475 |
| 2026-03-31 | 3,180,446 | -0.0% | 1.00 | 4,731,479 |
| 2026-03-13 | 3,181,601 | -13.8% | 3.05 | 1,043,357 |
| 2026-02-27 | 3,692,559 | -17.9% | 3.70 | 998,318 |
| 2026-02-13 | 4,499,122 | -1.2% | 2.83 | 1,591,642 |
| 2026-01-30 | 4,553,143 | -6.0% | 2.03 | 2,241,195 |
| 2026-01-15 | 4,843,122 | -46.6% | 1.00 | 18,961,362 |
| 2025-12-31 | 9,076,552 | +194.4% | 1.22 | 7,415,424 |
| 2025-12-15 | 3,082,849 | -8.0% | 1.32 | 2,330,013 |
| 2025-11-28 | 3,350,485 | -17.5% | 1.00 | 4,333,514 |
| 2025-11-14 | 4,060,839 | +69.3% | 1.00 | 5,971,455 |
| 2025-10-31 | 2,398,089 | +10.6% | 2.18 | 1,099,288 |
| 2025-10-15 | 2,168,058 | -51.1% | 1.00 | 2,296,203 |
| 2025-09-30 | 4,436,035 | -17.1% | 1.84 | 2,413,037 |
import finzdata as yf
yf.Ticker("OTLK").short_interest # every report since 2017
yf.Client().short_interest(["OTLK"], start="2018-01-01")Healthcare short interest · OTLK price history · Who owns OTLK · All short interest